Lone and secondary nonvalvular atrial fibrillation: Role of a genetic susceptibility

International Journal of Cardiology

Volumn 120, Issue 1, 2007, Pages 59-65

  Fatini, Cinzia ^a   Sticchi, Elena ^a,b   Gensini, Francesca ^c   Gori, Anna Maria ^a   Marcucci, Rossella ^a   Lenti, Meri ^a   Michelucci, Antonio ^a   Genuardi, Maurizio ^c   Abbate, Rosanna ^a   Gensini, Gian Franco ^a,b  

^a Center for the Study at Molecular and Clinical Level of Chronic   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

ACE I D polymorphism; Nonvalvular atrial fibrillation; Predisposition to disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; AGED; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONVALVULAR ATRIUM FIBRILLATION; PRIORITY JOURNAL; SEX RATIO; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34347361673     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.079     Document Type: Article

References (34)

1. Peters N.S., Schilling R.J., Kanagaratnam P., and Markides V. Atrial fibrillation: strategies to control, combat, and cure. Lancet 359 (2002) 593-603
2. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
3. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study. JAMA 271 (1994) 840-844
4. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20 (1992) 1433
5. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86 (1990) 1343-1346
6. Hamdi H.K., and Castellon R. A genetic variant of ACE increases cell survival: a new paradigm for biology and disease. Biochem Biophys Res Commun 318 (2004) 187-191
7. Suehiro T., Morita T., Inoue M., Kumon Y., Ikeda Y., and Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 115 (2004) 91-96
8. Gharavi A.G., Lipkowitz M.B., Diamond J.A., Jhang J.S., and Phillips R.A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodelling in systemic hypertension. Am J Cardiol 77 (1996) 1315-1319
9. Schut A.F., Bleumink G.S., Stricker B.H., et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 25 (2004) 2143-2148
10. Fatini C., Abbate R., Pepe G., et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 21 (2000) 633-638
11. Ogimoto A., Hamada M., Nakura J., Miki T., and Hiwada K. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy. J Hum Genet 47 (2002) 184-189
12. Goette A., Staack T., Rocken C., et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2000) 1669-1677
13. McEwan P.E., Gray G.A., Sherry L., Webb D.J., and Kenyon C.J. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 98 (1998) 2765-2773
14. Gensini F., Padeletti L., Fatini C., Sticchi E., Gensini G.F., and Michelucci A. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. PACE 26 (2003) 295-298
15. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. ESH/ESC hypertension guidelines committee. Hypertension 21 (2003) 1779-1786
16. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
17. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (2003) S5-S20
18. Vasan R.S., Larson M.G., Levy D., Evans J.C., and Benjamin E.J. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 96 (1997) 1863-1873
19. Fatini C., Gensini F., Sticchi E., et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 33 (2003) 642-647
20. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20 (1992) 1433
21. Sugden P.H., and Clerk A. Regulation of the ERK subgroup of MAP kinase cascade through G protein-coupled receptors. Cell Signal 9 (1997) 337-351
22. Sugden P.H., and Clerk A. Stress-responsive mitogen-activated protein kinase (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83 (1998) 345-352
23. Brilla C.G., Zhou G., Matsubara L., and Weber K.T. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26 (1994) 809-820
24. Dostal D.E. Regulation of cardiac collagen, angiotensin and cross-talk with local growth factors. Hypertension 37 (2001) 841-844
25. Ashizawa N., Graf K., Do Y.S., et al. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest 98 (1996) 2218-2227
26. Rothermund L., Kreutz R., Kossmehl P., et al. Early onset of chondroitin sulphate and osteopontin expression in angiotensin II-dependent left ventricular hyperthrophy. Am J Hypertens 15 (2002) 644-652
27. Ocaranza M.P., Diaz-Araya G., Carreno J.E., et al. Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats. Am J Physiol Heart Circ Physiol 286 (2004) H498-H506
28. Takahashi T., Ueno H., Yasumoto K., et al. Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension. J Hypertens 21 (2003) 985-991
29. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
30. Zaman A.G., Kearney M.T., Schecter C., Worthley S.G., and Nolan J. Angiotensin converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J 147 (2004) 823-827
31. Ueda S., Meredith P.A., Morton J.J., Connell J.M., and Elliott H.L. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enaprilat) in humans. Circulation 98 (1998) 2148-2153
32. Ribichini F., Steffenino G., Dellavalle A., et al. Plasma activity and insertion/deletion polymorphism of angiotensin I converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 97 (1998) 147-154
33. Healey J.S., Baranchuk A., Crystal E., et al. Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. J Am Coll Cardiol 45 (2005) 1832-1839
34. Boldt A., Scholl A., Garbade J., et al. ACE inhibitor treatment attenuates atrial structural remodelling in patients with lone chronic atrial fibrillation. Basic Res Cardiol 100 (2005) 1-7